Dr Peter Simon Herman, MD - Medicare Dermatology in El Paso, TX

Dr Peter Simon Herman, MD is a medicare enrolled "Dermatology" physician in El Paso, Texas. He graduated from medical school in 1962 and has 62 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Peter S Herman Md Pa and his current practice location is 2100 N Mesa, Peter S Herman Md Pa, El Paso, Texas. You can reach out to his office (for appointments etc.) via phone at (915) 544-3800.

Dr Peter Simon Herman is licensed to practice in Texas (license number E3304) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1669464285.

Contact Information

Dr Peter Simon Herman, MD
2100 N Mesa, Peter S Herman Md Pa,
El Paso, TX 79902-3312
(915) 544-3800
(915) 544-3008



Physician's Profile

Full NameDr Peter Simon Herman
GenderMale
SpecialityDermatology
Experience62 Years
Location2100 N Mesa, El Paso, Texas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Peter Simon Herman graduated from medical school in 1962
  NPI Data:
  • NPI Number: 1669464285
  • Provider Enumeration Date: 08/19/2005
  • Last Update Date: 12/28/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 1254394257
  • Enrollment ID: I20041111000064

Medical Identifiers

Medical identifiers for Dr Peter Simon Herman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1669464285NPI-NPPES
8P2920OtherTXBCBS

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ND0900XDermatology - Dermatopathology 207N10002X (Texas)Secondary
207N00000XDermatology E3304 (Texas)Primary
207NI0002XDermatology - Clinical & Laboratory Dermatological Immunology E3304 (Texas)Secondary
207NS0135XDermatology - Procedural Dermatology E3304 (Texas)Secondary
207ND0900XDermatology - Dermatopathology E3304 (Texas)Secondary
207NP0225XDermatology - Pediatric Dermatology E3304 (Texas)Secondary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Peter S Herman Md Pa87290417282

News Archive

Maxim's high-performance microcontrollers help develop wearable medical and fitness products

Designers can now easily develop high-performance fitness and medical wearable devices with enhanced functionality using the MAX32630 and MAX32631 ARM Cortex-M4F microcontrollers from Maxim Integrated Products, Inc.

DiagnoCure to showcase Previstage GCC Colorectal Cancer Staging Test at ASCRS meeting

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported that its PrevistageTM GCC Colorectal Cancer Staging Test will be featured at the annual meeting of the American Society of Colon and Rectal Surgeons to be held in Vancouver, Canada, from May 15 to 17, 2011, with 3,000 expected attendees.

Depression common among youth in Rwanda orphaned by AIDS, genocide, survey finds

Depression is common among teenage and young adult orphans in Rwanda who head households and provide care for younger children, according to a survey conducted by researchers at Tulane University that was published last month in the Archives of Pediatrics and Adolescent Medicine, the New York Times reports.

Racial disparities found in results of surgery to remove diseased prostates

Black prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Peter Simon Herman allows following entities to bill medicare on his behalf.
Entity NamePeter S Herman Md Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1982816138
PECOS PAC ID: 8729041728
Enrollment ID: O20041110000911

News Archive

Maxim's high-performance microcontrollers help develop wearable medical and fitness products

Designers can now easily develop high-performance fitness and medical wearable devices with enhanced functionality using the MAX32630 and MAX32631 ARM Cortex-M4F microcontrollers from Maxim Integrated Products, Inc.

DiagnoCure to showcase Previstage GCC Colorectal Cancer Staging Test at ASCRS meeting

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported that its PrevistageTM GCC Colorectal Cancer Staging Test will be featured at the annual meeting of the American Society of Colon and Rectal Surgeons to be held in Vancouver, Canada, from May 15 to 17, 2011, with 3,000 expected attendees.

Depression common among youth in Rwanda orphaned by AIDS, genocide, survey finds

Depression is common among teenage and young adult orphans in Rwanda who head households and provide care for younger children, according to a survey conducted by researchers at Tulane University that was published last month in the Archives of Pediatrics and Adolescent Medicine, the New York Times reports.

Racial disparities found in results of surgery to remove diseased prostates

Black prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Peter Simon Herman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Peter Simon Herman, MD
2100 N Mesa, Peter S Herman Md Pa,
El Paso, TX 79902-3312

Ph: (915) 544-3800
Dr Peter Simon Herman, MD
2100 N Mesa, Peter S Herman Md Pa,
El Paso, TX 79902-3312

Ph: (915) 544-3800

News Archive

Maxim's high-performance microcontrollers help develop wearable medical and fitness products

Designers can now easily develop high-performance fitness and medical wearable devices with enhanced functionality using the MAX32630 and MAX32631 ARM Cortex-M4F microcontrollers from Maxim Integrated Products, Inc.

DiagnoCure to showcase Previstage GCC Colorectal Cancer Staging Test at ASCRS meeting

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported that its PrevistageTM GCC Colorectal Cancer Staging Test will be featured at the annual meeting of the American Society of Colon and Rectal Surgeons to be held in Vancouver, Canada, from May 15 to 17, 2011, with 3,000 expected attendees.

Depression common among youth in Rwanda orphaned by AIDS, genocide, survey finds

Depression is common among teenage and young adult orphans in Rwanda who head households and provide care for younger children, according to a survey conducted by researchers at Tulane University that was published last month in the Archives of Pediatrics and Adolescent Medicine, the New York Times reports.

Racial disparities found in results of surgery to remove diseased prostates

Black prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more News

› Verified 9 days ago


Dermatology Doctors in El Paso, TX

Adrian Matthew Guevara, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 310 S Mesa Hills Dr Ste B, El Paso, TX 79912
Phone: 915-351-7546    Fax: 915-503-2791
Dr. Brett A Ozanich, D.O.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 310 S Mesa Hills Dr, El Paso, TX 79912
Phone: 915-351-7546    Fax: 915-351-3545
Dr. Mark Franklin Peake, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 8820 Gateway Blvd N, El Paso, TX 79904
Phone: 915-759-7700    Fax: 915-759-7778
Mr. David Vainsencher, MD
Dermatology
Medicare: Medicare Enrolled
Practice Location: 3607 Rivera Ave, El Paso, TX 79905
Phone: 915-533-7057    Fax: 915-533-7057
Dr. Hector Lastra Franco, M.D.
Dermatology
Medicare: Medicare Enrolled
Practice Location: 10500 Vista Del Sol Dr, Suite C, El Paso, TX 79925
Phone: 915-598-1959    Fax: 915-598-1986
Dr. Michael Homer Simpson, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1700 Murchison Dr, Suite 215, El Paso, TX 79902
Phone: 915-544-3254    Fax: 915-544-1203
Dr. Clinton Allen King, MD
Dermatology
Medicare: May Accept Medicare Assignments
Practice Location: 10657 Vista Del Sol, Suite A, El Paso, TX 79935
Phone: 915-598-3943    Fax: 915-598-3557

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.